How to Buy Alkermes Stock
Alkermes PLC
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally.
Alkermes stock last closed at $29.32, down 0.2% from the previous day, and has decreased 0.14% in one year. It has underperformed other stocks in the Biotechnology industry by 0.02 percentage points. Alkermes stock is currently +34.8% from its 52-week low of $21.75, and -9.03% from its 52-week high of $32.23.
At the moment, there are 166.12M ALKS shares outstanding. The market cap of ALKS is $4.87B. In the past 24 hours, 601,380 ALKS shares were traded.
How to Buy Alkermes Stock
Wondering how to invest in Alkermes stock? Here's how.
- Figure out where to buy Alkermes stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Alkermes stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Pick your method of payment and add your information.
- Research Alkermes stock: The Alkermes ticker symbol is ALKS. Is Alkermes stock a good investment? Should you buy shares of ALKS? How do ALKS's underlying business fundamentals look? Do top analysts think Alkermes is a good buy? Why has ALKS's stock price moved recently? (Hint: Our stock research tools can help you decide if ALKS is a good stock to buy).
- Place your ALKS purchase: Decide if you will purchase ALKS shares at the current market price or use a limit order to buy ALKS stock at a particular price.
- Get notifications regarding your ALKS investment: Create a watchlist to get the latest news on your new investment in Alkermes shares.
Step 1: Figure out where to buy Alkermes stock
You need a brokerage account to access the NASDAQ market and buy ALKS shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Financial Services, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal info so you are able to invest in ALKS stock today.
How to Start a New Investment Account on eToro
- Click here to get started.
- Enter your personal info to start a new trading account.
- Send your application by pressing the "Create Account" button.
Step 3: Deposit money your investment account
Now that you've created your account on a good online stock trading app, you need to deposit funds:
Watch the walkthrough below if you need help depositing funds into your investment account.
Step 4: Research Alkermes stock
Once you have figured out the best place to buy Alkermes stock, it's absolutely critical to research their stock prior to buying, so you truly wrap your head around the risk as well as the opportunity.
Alkermes stock quick numbers
Alkermes Fundamentals
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on ALKS's stock page.
Is ALKS stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge ALKS's true value.
Using relative valuations measures:
- ALKS could be undervalued based on its P/B ratio of 4.84x, relative to Biotechnology industry P/B ratio of 5.18x
You can access more valuation research on ALKS's stock here.
ALKS Financial Summary
Positive Health Checks:
- ALKS has $600.46M in cash and short term investments. This is enough to cover its annual cash burn of $59.26M.
- There are more short-term assets than long-term liabilities on the ALKS balance sheet.
- There are more short-term assets than short-term liabilities on the ALKS balance sheet.
- ALKS has cash burn of 59260000. It has enough cash and short-term investments to cover this for at least one year.
Negative Health Checks:
- ALKS profit margin has gone down from -5.1% to -14.7% in the past year.
- ALKS has a relatively high debt to equity ratio of 0.91.
- Total ALKS debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy ALKS stock
Out of 3 sell side analysts who give ratings on ALKS, the consensus analyst rating on ALKS is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent ALKS Analyst Upgrades/Downgrades
Uy Ear, a bottom 7% analyst from Mizuho maintains ALKS with a strong buy rating and lowers their ALKS price target from $37.00 to $36.00, on Apr 27, 2023.
Douglas Tsao, a top 10% analyst from HC Wainwright & Co. maintains ALKS with a hold rating and raises their ALKS price target from $32.00 to $34.00, on Apr 27, 2023.
Jessica Fye, a top 12% analyst from JP Morgan maintains ALKS with a hold rating and raises their ALKS price target from $29.00 to $31.00, on Apr 25, 2023.
You can dive deeper into what analysts are projecting on the Alkermes stock forecast page.
ALKS Momentum
ALKS Performance Metrics
Last year, ALKS revenue was $1.12B. Over the past 5 year, ALKS's revenue has grown by 3.65% per year. This was slower than the Biotechnology industry average of 89.01%.
You can research ALKS's earnings and revenue performance here.
What are ALKS executives and large shareholders up to?
Over the last 12 months, executives and large shareholders at ALKS have sold more shares than they have bought.
Nancy Wysenski, Director of ALKS, was the latest ALKS insider to sell. They sold $1,288,773.75 worth of ALKS stock on May 9, 2023.
Research more about who owns ALKS shares here.
Can I rely on ALKS as an income stream?
No, Alkermes doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your ALKS purchase
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount limit, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you want additional help investing in stocks on eToro, watch the helpful video below:
Step 6: Get notifications regarding your ALKS investment
Now that you own some shares in ALKS, you'll want to stay up-to-date on your new shares.
Add ALKS to a watchlist to track the latest developments regarding your ALKS stock.
ALKS Feed
How to Buy Stock in Alkermes
To reiterate, here are the 6 steps for buying Alkermes stock:
- Figure out where to buy Alkermes stock
- Open a brokerage account
- Deposit money your investment account
- Research Alkermes stock
- Place your ALKS purchase
- Get notifications regarding your ALKS investment
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your investment in Alkermes, create your watchlist below.
Related Content
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.